Skip to content

Diffusion-weighted Cerebral MRI and Intra Uterine Growth Restriction.

Prognostic Value of Diffusion-weighted Cerebral MRI in Prenatal Evaluation of Foetuses With Intra Uterine Growth Restriction.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02229630
Acronym
REDIFF
Enrollment
82
Registered
2014-09-01
Start date
2015-03-11
Completion date
2019-10-17
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnant Women With Foetuses Presenting With Intra-uterine Growth Restriction

Keywords

intra-uterine growth restriction, MRI, apparent diffusion coefficient

Brief summary

The purpose of this study is to compare the apparent diffusion coefficient in the frontal lobe of foetuses with intra-uterine growth restriction and poor neonatal outcome compared with foetuses with intra-uterine growth restriction and a good neonatal outcome.

Detailed description

Intra-uterine growth restriction is associated with an increased risk of perinatal morbimortality. The objective of foetal monitoring is to assess foetal growth, foetal well-being and to evaluate ability to adapt to chronic hypoxia. The primary objective in antenatal care is to ischemic cerebral lesions. However, there is currently no relevant prenatal exam predictive for the risk of such lesions. Foetal cerebral MRI could highlight changes in Apparent Diffusion Coefficient (ADC) in some frontal cerebral territories in foetuses with intra-uterine growth restriction and poor neonatal outcome. These changes could be associated with a transient cerebral ischemia. The study of ADC could be a useful tool in the prognostic evaluation of these foetuses.

Interventions

RADIATIONPregnant women with intra-uterine growth restricted Foetuses

Diffusion-weighted cerebral MRI before 32 weeks of gestation

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France
CollaboratorOTHER_GOV
URC-CIC Paris Descartes Necker Cochin
CollaboratorOTHER
Assistance Publique - Hôpitaux de Paris
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SCREENING
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* single pregnancy * estimated foetal weight ≤ 5th percentile * agreeing to participate * women age ≥ 18 years of age, speaking and understanding French language * covered by the French social security system

Exclusion criteria

* foetal malformation or foetal karyotype abnormal * infectious foetopathy * multiple pregnancy * refusal to participate * pregnant women aged \< 18 years old * pregnant women not understanding or speaking French language * not covered by French social security * contraindication to MRI

Design outcomes

Primary

MeasureTime frameDescription
Poor neonatal statusAt birthNeonatal death; Apgar score \< 7 at 5 min, immediate transfer to neonatal resuscitation unit; cordon arterial pH \< 7.10

Secondary

MeasureTime frameDescription
Poor neonatal statusuntil 30 days of lifeNecrositing enterocolitis with need for surgical intervention; convulsions; intraventricular haemorrhage (type I to IV); periventricular leukomalacia (diagnosed by MRI); transfer to neonatal intensive care unit
Neonatal status at neonatology unit dischargeup to 20 weeksNeurological status: normal / abnormal; need in O2: Yes/No
Neurological developmentAt 2 years of age (adjusted age)Age and stages questionnaire (ASQ)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026